These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6702778)

  • 1. Use of antiplatelet agents in pediatric hypercoagulable states.
    Hathaway WE
    Am J Dis Child; 1984 Mar; 138(3):301-4. PubMed ID: 6702778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of platelet function in pediatric medicine (author's transl)].
    Schmidt B
    Klin Padiatr; 1982 Mar; 194(2):91-3. PubMed ID: 7098376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet suppressive therapy.
    Turpie AG; Hirsh J
    Br Med Bull; 1978 May; 34(2):183-90. PubMed ID: 350343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with antiplatelet drugs. Current status of knowledge].
    Dettori AG; Pini M; Quintavalla R
    Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA; Hirsh J; Gent M; Genton E
    Prog Hematol; 1975; 9():229-54. PubMed ID: 766074
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet inhibition in the management of thrombosis.
    Didisheim P; Kazmier FJ; Fuster V
    Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of anti-platelet agents].
    Lecompte T; Kher A; Gaillard JL; Samama M
    J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet drugs in the management of patients with thrombotic disorders.
    Harker LA
    Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 12. Actions and clinical status of platelet-suppressive agents.
    Didisheim P; Fuster V
    Semin Hematol; 1978 Jan; 15(1):55-72. PubMed ID: 341328
    [No Abstract]   [Full Text] [Related]  

  • 13. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC
    Am J Hosp Pharm; 1978 Dec; 35(12):1507-15. PubMed ID: 362914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet and fibrinogen consumption in man.
    Harker LA; Slichter SJ
    N Engl J Med; 1972 Nov; 287(20):999-1005. PubMed ID: 4675535
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of common antiplatelet drugs for vascular diseases.
    Pagano T; Nair CK; Sketch MH
    Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole.
    Arenson EB; August CS
    J Pediatr; 1975 Jun; 86(6):957-61. PubMed ID: 1127537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microangiopathic hemolytic anemia].
    Hilgard P; Hiemeyer V
    Dtsch Med Wochenschr; 1972 Feb; 97(6):204-6. PubMed ID: 4550750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.